Evidence of a disturbance of the hypothalamic-pltuitary-adrenal axis in polycystic ovary syndrome: effect of naloxone-Reference-Cited by-同舟云学术

Evidence of a disturbance of the hypothalamic-pltuitary-adrenal axis in polycystic ovary syndrome: effect of naloxone

Published:1996-07 Issue:1 Volume:45 Page:73-77
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:

Author:

Lanzone Antonio,Guido Maurlzlo,Ciampelli Mario,Fulghesu Anna Maria,Pavone Virginia,Proto Caterina,Caruso Alessandro,Mancuso Salvatore

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1996.tb02062.x/fullpdf

Reference27 articles.

1. Differential response to adrenocorticotropin hormone stimulation in polycystic ovarian disease with high and low dehydroepiandrosterone sulfate levels;Ajers;Fertility and Sterility,1982

2. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor;DeBold;Journal of Clinical Investigation,1984

3. Opioid peptide and a-adrenoceptor pathways in the regulation of the pituitary adrenal axis in man;Delitala;Journal of Endocrinology,1994

4. On the site of action of naloxone-stimulated cortisol secretion in gilts;Estienne;Life Science,1988

5. Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease;Fulghesu;Obstetrics and Gynecology,1993

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rodent models of mental illness in polycystic ovary syndrome: the potential role of hypothalamic–pituitary–adrenal dysregulation and lessons for behavioral researchers;Biology of Reproduction;2018-11-01

2. Borderline personality disorder and polycystic ovary syndrome: A review of the literature;Australian & New Zealand Journal of Psychiatry;2017-09-09

3. Late-Night Salivary Cortisol is Unaltered in Patients With Polycystic Ovarian Syndrome (PCOS), Irrespective of Disease Phenotype, and in Obese Women, Irrespective of the Presence of PCOS;Endocrine Practice;2017-09

4. Cortisol and the polycystic ovary syndrome;Expert Review of Endocrinology & Metabolism;2012-09

5. Drugs and HPA axis;Pituitary;2008-04-11